CBOE · OCTW
AllianzIM U.S. Equity Buffer20 Oct ETF
$41.97-$0.31 (-0.73%)
AllianzIM U.S. Equity Buffer20 Oct ETF’s quoted price sits in the upper half of its reported 52-week range, 1.18% below the high.
Loading market information…
AMEX · TOV · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:52 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
JLens 500 Jewish Advocacy U.S. ETF’s quoted price sits in the upper half of its reported 52-week range, 3.91% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
JLens 500 Jewish Advocacy U.S. ETF’s forward annual dividend is $0.27 per share, paid quarterly. The forward yield is 0.86% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The JLens 500 Jewish Advocacy U.S. ETF is a U.S.-domiciled exchange-traded fund. Its core objective is to replicate the total returns of the JLens 500 Jewish Advocacy U.S. Index, measured before any fees or expenses are applied. This benchmark index is composed of large-capitalization U.S. equity securities, selected from the broader VettaFi US Equity Large-Cap 500 Index, while also ensuring strict adherence to JLens' Jewish value principles.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 11:35 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$41.97-$0.31 (-0.73%)
AllianzIM U.S. Equity Buffer20 Oct ETF’s quoted price sits in the upper half of its reported 52-week range, 1.18% below the high.
$32.20-$0.33 (-1.0%)
Bluemonte Large Cap Value ETF’s quoted price sits in the upper half of its reported 52-week range, 1.34% below the high.
$42.94-$0.88 (-2.02%)
ARS Focused Opportunity Strategy ETF’s quoted price sits in the upper half of its reported 52-week range, 10.53% below the high.
$40.47+$0.38 (+0.95%)
ETC 6 Meridian Low Beta Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 1.1% below the high.
$42.72-$0.80 (-1.84%)
Astoria US Equal Weight Quality Kings ETF’s quoted price sits in the upper half of its reported 52-week range, 3.82% below the high.
$25.83-$0.11 (-0.44%)
SEI DBi Multi-Strategy Alternative ETF’s quoted price sits in the lower half of its reported 52-week range, 4.49% below the high.
$51.05-$3.14 (-5.79%)
Goldman Sachs Future Tech Leaders Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 19.25% below the high.
$92.77-$0.19 (-0.2%)
Invesco Bloomberg Pricing Power ETF’s quoted price sits in the upper half of its reported 52-week range, 1.47% below the high.
